(Q95275836)

English

COVID-19 in persons with multiple sclerosis treated with ocrelizumab - a pharmacovigilance case series

scientific article published on 16 May 2020

Statements

COVID-19 in persons with multiple sclerosis treated with ocrelizumab - a pharmacovigilance case series (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit